Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets-Reference-Cited by-同舟云学术

Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets

Published:2019-05-13 Issue:6 Volume:129 Page:2463-2479
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Monette Anne,Morou Antigoni,Al-Banna Nadia A.,Rousseau Louise,Lattouf Jean-Baptiste,Rahmati Sara,Tokar Tomas,Routy Jean-Pierre,Cailhier Jean-François,Kaufmann Daniel E.,Jurisica Igor^ORCID,Lapointe Réjean

Funder

Canadian Cancer Society Research Institute grant

Kidney Foundation of Canada

Terry Fox Research Institute

Fonds de recherche Québec - Santé

Canadian Institutes of Health Research

National Heart, Lung, and Blood Institute

Canada Foundation for Innovation

Canada Research Chair Program

Ontario Research Fund

Mitacs

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/125301/files/pdf

Reference78 articles.

1. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival;Morris;Oncotarget,2016

2. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition

3. The prognostic landscape of genes and infiltrating immune cells across human cancers

4. Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors

5. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Role of FASLG in Inducing T Cell Exhaustion to Facilitate Immune Escape in Non-Small Cell Lung Cancer: A Bioinformatics-Based Study;J BIOL REG HOMEOS AG;2024

2. NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma;Frontiers in Genetics;2022-07-26

3. Information fusion as an integrative cross-cutting enabler to achieve robust, explainable, and trustworthy medical artificial intelligence;Information Fusion;2022-03

4. Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer;Frontiers in Oncology;2021-08-30

5. CD40L-Stimulated B Lymphocytes Are Polarized toward APC Functions after Exposure to IL-4 and IL-21;The Journal of Immunology;2021-06-16